These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10811476)

  • 1. Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production.
    Karpoff HM; Kooby D; D'Angelica M; Mack J; Presky DH; Brownlee MD; Federoff H; Fong Y
    Cancer Gene Ther; 2000 Apr; 7(4):581-8. PubMed ID: 10811476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH; Carew JF; Kooby DA; Shields J; Entwisle C; Patel S; Shah JP; Fong Y
    Cancer Gene Ther; 2000 Sep; 7(9):1279-85. PubMed ID: 11023201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
    Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.
    Jarnagin WR; Zager JS; Klimstra D; Delman KA; Malhotra S; Ebright M; Little S; DeRubertis B; Stanziale SF; Hezel M; Federoff H; Fong Y
    Cancer Gene Ther; 2003 Mar; 10(3):215-23. PubMed ID: 12637943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine.
    Toda M; Martuza RL; Rabkin SD
    Gene Ther; 2001 Feb; 8(4):332-9. PubMed ID: 11313808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific organ gene transfer in vivo by regional organ perfusion with herpes viral amplicon vectors: implications for local gene therapy.
    Brooks AD; Ng B; Liu D; Brownlee M; Burt M; Federoff HJ; Fong Y
    Surgery; 2001 Mar; 129(3):324-34. PubMed ID: 11231461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
    Tsuchiyama T; Kaneko S; Nakamoto Y; Sakai Y; Honda M; Mukaida N; Kobayashi K
    Cancer Gene Ther; 2003 Apr; 10(4):260-9. PubMed ID: 12679798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
    Toda M; Martuza RL; Kojima H; Rabkin SD
    J Immunol; 1998 May; 160(9):4457-64. PubMed ID: 9574551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total vascular exclusion of the liver enhances the efficacy of retroviral-mediated associated thymidine kinase and interleukin-2 genes transfer against multiple hepatic tumors in rats.
    Alves A; Charre L; Panis Y; Cardoso J; Fabre M; Brisson E; Houssin D; Soubrane O; Klatzmann D
    Surgery; 2003 Jun; 133(6):669-77. PubMed ID: 12796736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.
    Karpoff HM; D'Angelica M; Blair S; Brownlee MD; Federoff H; Fong Y
    J Clin Invest; 1997 Feb; 99(4):799-804. PubMed ID: 9045885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production.
    Tung C; Federoff HJ; Brownlee M; Karpoff H; Weigel T; Brennan MF; Fong Y
    Hum Gene Ther; 1996 Dec; 7(18):2217-24. PubMed ID: 8953312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
    Zibert A; Thomassen A; Müller L; Nguyen L; Glouchkova L; Fraefel C; Roskrow M; Meisel R; Dilloo D
    Gene Ther; 2005 Dec; 12(23):1707-17. PubMed ID: 16034459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness.
    Govaerts AS; Guillaume T; André M; Bayat B; Feyens AM; Hawley TS; Fong AZ; Hawley RG; Symann M
    Cancer Gene Ther; 1999; 6(5):447-55. PubMed ID: 10505855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
    Gao JQ; Kanagawa N; Motomura Y; Yanagawa T; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Gene Ther; 2007 Mar; 14(6):491-502. PubMed ID: 17203106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
    Su H; Lu R; Ding R; Kan YW
    Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.
    Lieu FH; Hawley TS; Fong AZ; Hawley RG
    Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells.
    Geutskens SB; van der Eb MM; Plomp AC; Jonges LE; Cramer SJ; Ensink NG; Kuppen PJ; Hoeben RC
    Gene Ther; 2000 Aug; 7(16):1410-6. PubMed ID: 10981668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy.
    Ino Y; Saeki Y; Fukuhara H; Todo T
    Clin Cancer Res; 2006 Jan; 12(2):643-52. PubMed ID: 16428511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.